Review Article
Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders
Table 2
Molecular protocols employed for detection of C. pneumoniae in clinical specimens from MS patients.
| MS patients (positive/total) | Controls (positive/total) | PCR assay | References |
| 7/30 (23%) | 0/56 (0%) | n-PCR† | Layh-Schmitt et al. 2000 [81] | 9/17 (52%) | 13/15 (86%) | PCR† | Li et al. 2000 [82] | 2/8 (25%) | | not reported† | Treib et al. 2000 [83] | 12/58 (21%) | 20/47 (43%) | n-PCR† | Gieffers et al. 2001 [84] | 3/32 (9%) | 0/30 (0%) | PCR† | Sotgiu et al. 2001 [85] | 11/16 (69%) | | PCR† | Ikejima et al. 2001 [86] | 9/28 (32%) | 2/15 (13%) | PCR† | Hao et al. 2002 [87] | 2/70 (2.9%) | 0/30 (0%) | n-PCR† | Chatzipanagiotou et al. 2003 [88] | 23/107 (21%) | 2/77 (3%) | Touchdown n-PCR† | Grimaldi et al. 2003 [89] | 2/25 (8%) | 3/28 (11%) | n-PCR and semi-n-PCR† | Rostasy et al. 2003 [90] | 42/84 (50%) | 25/89 (28%) | Touchdown n-PCR, RT-PCR† | Dong-Si et al. 2004 [91] | 26/71 (36.6%) | 24/72 (33.3%) | Touchdown n-PCR† | Contini et al. 2004 [92] | 12/20 (60%) | 1/12 (8%) | Touchdown n-PCR† | Sriram et al. 2005 [93] | 2/112 (2%) | 0/110 (0%) | Real-time PCR‡ | Sessa et al. 2007 [94] | 7–9/14 (50–64.3%)† | 0-1/19 (0–5.2%)† | Touchdown n-PCR, |
Contini et al. 2008 [95] | 5–7/14 (35.7–50%)‡ | 0–2/19 (0–10.5 %)‡ | RT-PCR†‡, | 64/80 (80%) | 5/57 (9%) | PCR-EIA, Touchdown n-PCR, Real Time-PCR† | Tang et al. 2009 [96] |
|
|
n-PCR: nested PCR; RT-PCR: reverse transcriptase PCR; PCR-EIA: PCR enzyme immunoassay; †, CFS: cerebrospinal fluid; ‡, PBMC: peripheral blood mononuclear cells.
|